$EQBK

Schlehuber Lisa Ann purchased $50K of EQBK

Schlehuber Lisa Ann purchased 989 shares of EQUITY BANCSHARES INC (EQBK) at $50.98 on 2026-07-28.

Original reporting
SEC EDGAR · Schlehuber Lisa Ann
Published Jul 29, 2026, 6:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 6:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EQBK
Bullish
medium confidence
Mentioned
$EQBK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EQBKBullishLow
01

Why it matters

Traders may treat the disclosure as a minor positive sentiment datapoint, but it does not introduce new financial or operational information.

02

Market read

A modest director open-market buy is disclosed, offering limited incremental information for trading decisions.

03

What to watch

The filing does not provide a rationale, and the absence of a 10b5-1 plan does not confirm conviction; it only indicates the trade was not under a pre-arranged plan.

Relevance 4/10Novelty 3/10Timing: post-filing, after-hours/next-session read-through of the Form 4 disclosure

Background

The article is a primary-source SEC Form 4 insider transaction for Equity Bancshares Inc, reported by a director.

Company-level read

Ticker impact

$EQBKBullishMedium confidence
Context

Director Schlehuber Lisa Ann filed a Form 4 open-market purchase of 989 shares at $50.98 on 2026-07-28, totaling about $50.4K.

Expected impact

Low likelihood of a sustained price move; any reaction would be limited and short-lived.

Evidence & confidence

The transaction is an insider open-market purchase with modest dollar value and no 10b5-1 plan disclosed, but it does not include new company performance, guidance, or material corporate events.

Market effects

No sector-level implications; this is a single-company insider transaction.

No clear regional market impact indicated.

No global relevance beyond EQBK-specific sentiment.

Counterpoint

Insider buys can be routine or opportunistic and may not reflect a change in outlook, especially at small sizes.

Key entities

  • EQBK

    Equity Bancshares Inc, the company whose director filed the Form 4 insider purchase.

  • Schlehuber Lisa Ann

    Director who reported an open-market purchase of 989 shares at $50.98.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.